CD73 inhibitors

Described herein are CD73 inhibitors and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for the treatment of cancer, infections, and neurodegenerative diseases.

Saved in:
Bibliographic Details
Main Authors YEH, Chien-Hung, EKSTEROWICZ, John, MOORE, Jared, PHAM, Johnny, WU, Kejia, BLANK, Brian R, YE, Qiuping, REW, Yosup, ZAVOROTINSKAYA, Tatiana, ZHU, Liusheng, FANTIN, Valeria R, SUN, Daqing, DU, Xiaohui, KAWAI, Hiroyuki
Format Patent
LanguageEnglish
Published 02.06.2022
Subjects
CHEMISTRY
DERIVATIVES THEREOF
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
NUCLEIC ACIDS
NUCLEOSIDES
NUCLEOTIDES
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SUGARS
Online AccessGet full text

Cover

More Information
Summary:Described herein are CD73 inhibitors and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for the treatment of cancer, infections, and neurodegenerative diseases.
Bibliography:Application Number: AU20200375914